• Text size      
  • Send this article to a friend
  • Print this article

Tests could help men with prostate cancer

TESTING for an abnormal protein in the blood could identify men with prostate cancer who cannot be helped by two new drugs.

Patients whose tumours contain a shortened protein called AR-V7 do not respond to enzalutamide and abiraterone, research has shown.

The protein is detectable in the blood, raising the possibility of a test that could help doctors plan the best form of treatment for men with advanced prostate cancer.

Enzalutamide and abiraterone work in different ways to tackle prostate cancer that has become resistant to standard hormone treatments.

In a new study, no patients who tested positive for AR-V7 responded to either drug.

A large proportion of those who lacked the protein did respond.

Enzalutamide and abiraterone have proved highly successful in extending the lives of 80 per cent of men with advanced prostate cancer. However, they do nothing for the remaining 20 per cent. Scotland was the first part of the UK to approve the use of enzalutamide on the NHS when the Scottish Medicines Consortium announced its decision on the drug last year while abiraterone has been available since 2012.

But lead scientist Dr Emmanuel Antonarakis, from Johns Hopkins University in the US, said: "Patients whose blood samples contained AR-V7 got no benefit from either enzalutamide or abiraterone.

"Until now, we haven't been able to predict which patients will not respond to these therapies."

Contextual targeting label: 

Commenting & Moderation

We moderate all comments on HeraldScotland on either a pre-moderated or post-moderated basis.
If you're a relatively new user then your comments will be reviewed before publication and if we know you well and trust you then your comments will be subject to moderation only if other users or the moderators believe you've broken the rules

Moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours. Please be patient if your posts are not approved instantly.